Cyclopharm Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	12.41	20.57	11.73	20.3	29.25	1.87
Cash & Short-Term Investments	12.41	20.57	11.73	20.3	29.25	1.87
Cash Growth	-57.04%	75.40%	-42.22%	-30.61%	1460.55%	-85.20%
Accounts Receivable	4.66	4.91	5.74	5.25	4.66	5.35
Other Receivables	2.78	1.52	0.92	2.46	3.44	3.72
Receivables	7.45	6.43	6.67	7.71	8.1	9.07
Inventory	14.18	13.25	10.12	8.29	5.51	4.74
Other Current Assets	2.23	2.14	1.68	0.57	0.39	0.3
Total Current Assets	36.27	42.39	30.2	36.87	43.25	15.98
Property, Plant & Equipment	12.54	13.1	9.19	6.6	6.25	5.81
Goodwill	-	0.93	0.9	0.87	0.87	0.87
Other Intangible Assets	6.08	4.18	4.04	3.78	3.77	3.64
Long-Term Deferred Tax Assets	1.03	0.75	0.76	0.64	0.82	1.19
Long-Term Deferred Charges	-	0.79	0.79	0.79	0.79	0.79
Other Long-Term Assets	-	-	0.03	-	-	-
Total Assets	55.91	62.13	45.91	49.54	55.74	28.28
Accounts Payable	4.28	3.8	3.15	4.4	2.17	3.3
Accrued Expenses	3.22	2.76	1.48	1.13	1.23	1.02
Current Portion of Leases	0.62	0.63	0.21	0.21	0.18	0.15
Current Income Taxes Payable	0.01	-	0.04	0.09	0.1	0.11
Other Current Liabilities	3.23	3.43	3.79	2.1	3.73	1.1
Total Current Liabilities	11.36	10.61	8.67	7.94	7.42	5.68
Long-Term Leases	7.36	7.66	4.01	4.12	4.33	4.56
Long-Term Unearned Revenue	0.9	0.9	0.9	0.9	0.9	0.89
Other Long-Term Liabilities	0.19	0.22	0.07	0.05	0.03	0.02
Total Liabilities	19.81	19.4	13.65	13.01	12.67	11.16
Common Stock	92.41	92.41	69.11	68.75	68.31	36.97
Retained Earnings	-55.54	-47.86	-34.66	-29.07	-21.58	-15.66
Comprehensive Income & Other	-0.76	-1.82	-2.2	-3.14	-3.66	-4.19
Shareholders' Equity	36.1	42.73	32.26	36.54	43.07	17.12
Total Liabilities & Equity	55.91	62.13	45.91	49.54	55.74	28.28
Total Debt	7.98	8.29	4.23	4.33	4.51	4.71
Net Cash (Debt)	4.43	12.28	7.5	15.96	24.74	-2.83
Net Cash Growth	-81.00%	63.78%	-53.03%	-35.47%	-	-
Net Cash Per Share	0.04	0.12	0.08	0.17	0.28	-0.04
Filing Date Shares Outstanding	111.14	111.14	94.1	93.05	93.37	93.37
Total Common Shares Outstanding	111.14	111.14	94.1	93.05	93.37	80.27
Working Capital	24.9	31.77	21.53	28.93	35.83	10.29
Book Value Per Share	0.32	0.38	0.34	0.39	0.46	0.21
Tangible Book Value	30.02	37.62	27.31	31.89	38.43	12.61
Tangible Book Value Per Share	0.27	0.34	0.29	0.34	0.41	0.16
Land	-	2.41	2.45	0.5	0.55	0.51
Machinery	-	10.67	8.99	4.85	4.65	4.3
Construction In Progress	-	0.02	-	0.1	0.1	0.09
Leasehold Improvements	-	5.87	5.68	3.25	2.72	2.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.